Over the past 12 months, 0 insiders at Coya Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on COYA: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 14, 24 | David S SnyderChief Financial Officer | BUY | 1.8K | $7.19 | $13K |
| Nov 13, 24 | Arun SwaminathanChief Executive Officer | BUY | 5.0K | $7.36 | $37K |
| Nov 11, 24 | Fred GrossmanChief Medical Officer | BUY | 2.7K | $7.37 | $20K |
| Nov 11, 24 | Arun SwaminathanChief Executive Officer | BUY | 5.0K | $7.34 | $37K |
| Aug 22, 23 | Ann LeeDirector | BUY | 1.0K | $3.62 | $4K |
| Jan 3, 23 | Howard BermanChief Executive Officer | BUY | 10.0K | - | $0 |
| Jan 3, 23 | Goldstein Dov A MdDirector | BUY | 10.0K | - | $0 |
| Jan 3, 23 | Hideki GarrenDirector | BUY | 2.0K | - | $0 |
| Jan 3, 23 | Adrian HepnerChief Medical Officer | BUY | 10.0K | - | $0 |
| Jan 3, 23 | David S SnyderChief Financial Officer | BUY | 7.0K | - | $0 |
| Jan 3, 23 | Anabella VillalobosDirector | BUY | 10.0K | - | $0 |
| Jan 3, 23 | Ann LeeDirector | BUY | 10.0K | - | $0 |
Over the past 12 months, insiders at Coya Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on COYA, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market COYA insider purchase in our data was $37K by Arun Swaminathan, Chief Executive Officer, filed on Nov 13, 24.
0 different insiders at Coya Therapeutics, Inc. filed open-market SEC Form 4 transactions on COYA over the last 12 months.
InsiderTape plots every COYA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Coya Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →